key: cord-0903105-a3kuz7l8
authors: Pilecky, Matthias; Harm, Stephan; Bauer, Christoph; Zottl, Jennifer; Emprechtinger, Robert; Eichhorn, Tanja; Schildböck, Claudia; Ecker, Michael; Willheim, Martin; Weber, Viktoria; Hartmann, Jens
title: Performance of Lateral Flow Assays for SARS-CoV-2 compared to RT-qPCR
date: 2022-01-14
journal: J Infect
DOI: 10.1016/j.jinf.2022.01.013
sha: 1800542b4485c612bab7ba9f44a4946ea3a31460
doc_id: 903105
cord_uid: a3kuz7l8

nan

identify potential super-spreaders with low cT values and to prevent large cluster formation, e.g., in 78 hospitals 1,3,4 , however, regardless of the manufacturer, they are not likely to contribute significantly 79

to control the infection dynamics caused by carriers of low viral load or by asymptomatic individuals, 80

including those at early stages of infection. 81

It should be noted that cT values can vary among clinical laboratories, depending on the method for 82 RNA extraction and the PCR kits used. As an example, in a study involving 123 participating certified 83 laboratories in Austria including our lab, a variation in cT values of ± 4.7 cycles was observed 5 . 84 Samples in our study were exclusively obtained via nasopharyngeal swabs by professionals, whereas 85

other techniques, such as the common anterior nasal swab or incorrect swabbing by non-trained 86 personal may significantly decrease in vitro virus concentration, and thus can increase the cT-values 87 by several orders of magnitude 6-8 leading to a further loss of sensitivity. In the light of the repeated

Real-world evaluation of COVID-19 lateral flow device (LFD) mass-testing in 116 healthcare workers at a London hospital; a prospective cohort analysis

Covid-19: Tests on students are highly inaccurate, early findings show

Viral Load of Severe Acute Respiratory Syndrome Coronavirus 2 in Adults 121 During the First and Second Wave of Coronavirus Disease

Control of a COVID-19 outbreak in a 124 nursing home by general screening and cohort isolation in Germany

A look at the precision, sensitivity and specificity of SARS-CoV-2 RT-PCR assays 127 through a dedicated external quality assessment round

Self-Collected Anterior Nasal and Saliva Specimens versus Health Care 130 Worker-Collected Nasopharyngeal Swabs for the Molecular Detection of SARS-CoV-2

Quantifying the Impact of Nasopharyngeal Specimen Quality on 133

Severe Acute Respiratory Syndrome Coronavirus 2 Test Performance

Relative sensitivity of anterior nares and nasopharyngeal swabs for initial 136 detection of SARS-CoV-2 in ambulatory patients: Rapid review and meta-analysis

Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 139 pandemic

emergence of SARS-CoV-2 variants, one may also be worried about decreased sensitivity due to 89 altered surface proteins, which are recognized be the LFD antibodies 9 . 90Based on our data, we conclude that LFDs cannot be recommended for general broad-range 91 screening for SARS-CoV-2 infection in an asymptomatic population. At high infection dynamics 92however, insufficient PCR test capacities lead to logistic difficulties, an increased time-to-result, as 93 well as decreased sensitivity related to sample pooling. In such settings, the short time-to-result of 94LFDs may support the timely identification and isolation of individuals with high viral load to dampen 95 the dynamics of spread, as suggested by Lamb et al. 1